![P-0117 * GEMCITABINE(G)-ERLOTINIB(E) VERSUS GEMCITABINE-ERLOTINIB-CAPECITABINE(C) IN THE FIRST LINE TREATMENT OF PATIENTS WITH METASTATIC PANCREATIC CANCER (MPC): EFFICACY AND SAFETY RESULTS OF A PHASE IIB RANDOMIZED STUDY FROM SPANISH TTD COLLABORATIVE GROUP]()
P-0117 * GEMCITABINE(G)-ERLOTINIB(E) VERSUS GEMCITABINE-ERLOTINIB-CAPECITABINE(C) IN THE FIRST LINE TREATMENT OF PATIENTS WITH METASTATIC PANCREATIC CANCER (MPC): EFFICACY AND SAFETY RESULTS OF A PHASE IIB RANDOMIZED STUDY FROM SPANISH TTD COLLABORATIVE GROUPManuel, B.; Javier, G.; Carmen, G.-P.; Ruth, V.; Vega, I.; Inmaculada, A.; Sara, A.; Aleydis, P.; Marta, M.; Antonieta, S.; Esther, F.; Alberto, S.; Luis, M. J.; Gema, P.; Joaquina, M.-G.; Roberto, P.; Carlos, L.-L.; Teresa, G.; Olbia, S.; M, F.-P. E.; Antonio, I.; Enrique, A. · Annals of Oncology · 2014